News

Filter

Current filters:

MetabolicsRelvar

26 to 35 of 97565 results

First UK NICE highly specialized technologies guidance recommends Soliris

First UK NICE highly specialized technologies guidance recommends Soliris

28-01-2015

England’s health costs watchdog the National Institute for Health and care Excellence has today issued…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolarisUK

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

27-01-2015

Ireland-headquartered drugmaker Shire has received fast-track designation from the US Food and Drug Administration…

NeurologicalPharmaceuticalRegulationShireSHP609

US FDA approves Symplmed and Servier’s Prestalia

US FDA approves Symplmed and Servier’s Prestalia

27-01-2015

Privately-held US drugmaker Symplmed Pharmaceuticals says that the US Food and Drug Administration has…

Cardio-vascularPharmaceuticalPrestaliaRegulationServierSymplmedUSA

T-Bird Pharma appoints Sandy Pratt as chief financial officer

T-Bird Pharma appoints Sandy Pratt as chief financial officer

27-01-2015

Canadian medical marijuana therapy specialist T-Bird Pharma has appointed Sandy Pratt as chief financial…

BoardroomCanadaPharmaceuticalT-Bird Pharma

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

27-01-2015

US pharma giant Pfizer has announced commitments to reduce the price of Prevenar 13 (pneumococcal polysaccharide…

Medecins Sans FrontiersPfizerPharmaceuticalPrevenarPricingVaccines

26 to 35 of 97565 results

Back to top